INUVO INC (INUV)

US46122W2044 - Common Stock

0.34  +0.01 (+1.71%)

Premarket: 0.344 +0 (+1.18%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to INUV. INUV was compared to 276 industry peers in the Software industry. INUV has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, INUV is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

In the past year INUV has reported negative net income.
In the past year INUV has reported a negative cash flow from operations.
In the past 5 years INUV always reported negative net income.
INUV had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of INUV (-32.10%) is worse than 73.72% of its industry peers.
Looking at the Return On Equity, with a value of -61.19%, INUV is doing worse than 67.88% of the companies in the same industry.
Industry RankSector Rank
ROA -32.1%
ROE -61.19%
ROIC N/A
ROA(3y)-28.73%
ROA(5y)-24.31%
ROE(3y)-48.26%
ROE(5y)-41.91%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

INUV's Gross Margin of 85.83% is amongst the best of the industry. INUV outperforms 94.16% of its industry peers.
In the last couple of years the Gross Margin of INUV has grown nicely.
The Profit Margin and Operating Margin are not available for INUV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 85.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.78%
GM growth 5Y7.71%

2

2. Health

2.1 Basic Checks

INUV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for INUV has been increased compared to 1 year ago.
The number of shares outstanding for INUV has been increased compared to 5 years ago.
Compared to 1 year ago, INUV has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -4.16, we must say that INUV is in the distress zone and has some risk of bankruptcy.
INUV has a Altman-Z score of -4.16. This is amonst the worse of the industry: INUV underperforms 83.21% of its industry peers.
INUV has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
INUV has a Debt to Equity ratio of 0.00. This is in the better half of the industry: INUV outperforms 70.80% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.16
ROIC/WACCN/A
WACC10.15%

2.3 Liquidity

INUV has a Current Ratio of 1.01. This is a normal value and indicates that INUV is financially healthy and should not expect problems in meeting its short term obligations.
INUV has a Current ratio of 1.01. This is in the lower half of the industry: INUV underperforms 77.37% of its industry peers.
A Quick Ratio of 1.01 indicates that INUV should not have too much problems paying its short term obligations.
The Quick ratio of INUV (1.01) is worse than 76.28% of its industry peers.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 1.01

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 18.18% over the past year.
INUV shows a decrease in Revenue. In the last year, the revenue decreased by -2.23%.
Measured over the past years, INUV shows a small growth in Revenue. The Revenue has been growing by 0.16% on average per year.
EPS 1Y (TTM)18.18%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q33.33%
Revenue 1Y (TTM)-2.23%
Revenue growth 3Y18.3%
Revenue growth 5Y0.16%
Revenue growth Q2Q20.68%

3.2 Future

Based on estimates for the next years, INUV will show a very strong growth in Earnings Per Share. The EPS will grow by 37.36% on average per year.
Based on estimates for the next years, INUV will show a very strong growth in Revenue. The Revenue will grow by 20.10% on average per year.
EPS Next Y60.33%
EPS Next 2Y37.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year21.24%
Revenue Next 2Y20.1%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

INUV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year INUV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

INUV's earnings are expected to grow with 37.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.36%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for INUV!.
Industry RankSector Rank
Dividend Yield N/A

INUVO INC

NYSEARCA:INUV (4/29/2024, 7:07:15 PM)

Premarket: 0.344 +0 (+1.18%)

0.34

+0.01 (+1.71%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap47.33M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -32.1%
ROE -61.19%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 85.83%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.28
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.01
Quick Ratio 1.01
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)18.18%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y60.33%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-2.23%
Revenue growth 3Y18.3%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y